Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices

被引:113
作者
Kollef, NH
Ward, S
Sherman, G
Prentice, D
Schaiff, R
Huey, W
Fraser, VJ
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Barnes Jewish Hosp, Dept Nursing, St Louis, MO 63110 USA
[4] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA
关键词
antibiotics; nosocomial; infection; outcomes; critical care; pneumonia; bacteremia; bacteria; intensive care unit; Gram-negative;
D O I
10.1097/00003246-200010000-00014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this study was to determine the impact of scheduled changes of antibiotic classes, used for the empirical treatment of suspected or documented Gram-negative bacterial infections, an the occurrence of inadequate antimicrobial treatment of nosocomial infections. Design: Prospective observational study. Setting: Medical (19-bed) and surgical (18-bed) intensive care units in an urban teaching hospital. Patients: A total of 3,668 patients requiring intensive care unit admission were prospectively evaluated during three consecutive time periods. Interventions.. During each time period, one antibiotic class was selected far the empirical treatment of Gram-negative bacterial infections as follows: time period 1 (baseline period) (1,323 patients), ceftazidime; time period 2 (1,243 patients), ciprofloxacin; and time period 3 (1,102 patients), cefepime, Measurements and Main Results: The overall administration of inadequate antimicrobial treatment for nosocomial infections decreased during the course of the study (6.1%, 4.7%, and 4.5%; p = .15). This was primarily because of a statistically significant decrease in the administration of inadequate antibiotic treatment for Gram-negative bacterial infections (4.4%, 2.1%, and 1.6%; p < .001). There were no statistically significant differences in the overall hospital mortality rate among the three time periods (15.6%, 16.4%, and 16.2%; p = .828) despite a significant increase in severity of illness as measured with Acute Physiology and Chronic Health Evaluation (APACHE) II scores (15.3 +/- 7.6, 15.7 +/- 8.0, and 20.7 +/- 8.6; p < .001). The hospital mortality rate decreased significantly during time period 3 (20.6%) compared with time period 1 (28.4%; p < .001) and time period 2 (29.5%; p < .001) for patients with an APACHE II score greater than or equal to 15. Conclusions: These data suggest that scheduled changes of antibiotic classes for the empirical treatment of Gram-negative bacterial infections can reduce the occurrence of inadequate antibiotic treatment for nosacomial infections. Reducing inadequate antibiotic administration may improve the outcomes of critically ill patients with APACHE II scares greater than or equal to 15.
引用
收藏
页码:3456 / +
页数:10
相关论文
共 38 条
  • [1] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [2] NOSOCOMIAL PNEUMONIA - A MULTIVARIATE-ANALYSIS OF RISK AND PROGNOSIS
    CELIS, R
    TORRES, A
    GATELL, JM
    ALMELA, M
    RODRIGUEZROISIN, R
    AGUSTIVIDAL, A
    [J]. CHEST, 1988, 93 (02) : 318 - 324
  • [3] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [4] DUNAGAN WC, 1991, REV INFECT DIS, V13, P405
  • [5] A computer-assisted management program for antibiotics and other antiinfective agents
    Evans, RS
    Pestotnik, SL
    Classen, DC
    Clemmer, TP
    Weaver, LK
    Orme, JF
    Lloyd, JF
    Burke, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (04) : 232 - 238
  • [6] NOSOCOMIAL PNEUMONIA IN VENTILATED PATIENTS - A COHORT STUDY EVALUATING ATTRIBUTABLE MORTALITY AND HOSPITAL STAY
    FAGON, JY
    CHASTRE, J
    HANCE, AJ
    MONTRAVERS, P
    NOVARA, A
    GIBERT, C
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) : 281 - 288
  • [7] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [8] AMINOGLYCOSIDE RESISTANCE AND AMINOGLYCOSIDE USAGE - 10 YEARS OF EXPERIENCE IN ONE HOSPITAL
    GERDING, DN
    LARSON, TA
    HUGHES, RA
    WEILER, M
    SHANHOLTZER, C
    PETERSON, LR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1284 - 1290
  • [9] Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership
    Goldmann, DA
    Weinstein, RA
    Wenzel, RP
    Tablan, OC
    Duma, RJ
    Gaynes, RP
    Schlosser, J
    Martone, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03): : 234 - 240
  • [10] Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
    Hanberger, H
    Garcia-Rodriguez, JA
    Gobernado, M
    Goossens, H
    Nilsson, LE
    Struelens, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01): : 67 - 71